FDA Inspection
Ranbaxy Inc.Ranbaxy Inc. – FDA Inspection, Sep 29, 2009
Record Details
This FDA Inspection record concerns Ranbaxy Inc., with an inspection on September 29, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ranbaxy Inc.
- Inspection Date
- September 29, 2009
- Product Type
- Drugs
View Company Profile
ID · 1d956fe1-69df-485a-92b4-d64f6b413c02
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 612435
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ranbaxy Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 20, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 4, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 22, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ranbaxy Inc.
- FDA Inspection 1018135 - 2017-06-20
- FDA Inspection 893221 - 2014-09-04
- FDA Inspection 730758 - 2011-06-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.